Bullboard Post History

by Gman620

Order by:

V.TLT	RE:RE:RE:Impalaman I agree. Impala was positive when many were despairing. I'm sorry that he... 12 days ago
V.TLT	FDA focused? I hope that the people at the FDA are not distracted by shredding documents... November 21, 2024
V.TLT	RE:RE:Potential US election impact on the FDA? Unless a Theralase vaccine is proven by data to do more harm than good, RFK... November 7, 2024
V.TLT	RE:New Paper by Dr. McFarland Summarized by Chatgpt: Researchers created and studied five new iridium... October 25, 2024
V.TLT	No Money = No leverage If I'm a big pharma, I see a desperate company that is running out of... September 3, 2024
V.TLT	Exciting News.... coming No worries, it's not like funds are running low and things need to happen... August 8, 2024
V.TLT	37 more trial subjects TLT hired someone specifically to get those 37 trail subjects to make the... April 23, 2024
V.TLT	RE:RE:RE:RE:Quote from Keytruda.com Well, just following the money is an indicator. They are a lot farther along... January 25, 2024
V.TLT	RE:RE:Quote from Keytruda.com They have a standalone trial/treatment and one with Keytruda. There is... January 25, 2024
V.TLT	RE:RE:RE:RE:RE:RE:CG Oncology phase 3 results impossible for TLT to beat? Why should TLT get BTD with this out there? Having lots of treatments... January 25, 2024
V.TLT	RE:RE:Incremental cost per study subject? Right. Thanks. Not a great motivator to enrollment, but if you can fight the... January 22, 2024
V.TLT	Incremental cost per study subject? Does anyone have a sense what the incremental cost per study subject is to... January 22, 2024
V.TLT	RE:RE:RE:RE:RE:RE:Dr. Ashish Kamat Interview - BOND-003 Study Results Seems like they got a good sized study population pulled together pretty... January 9, 2024
V.TLT	Green Swimlanes From the video, It sounded like the FDA is requiring results from100 trial... January 8, 2024
V.TLT	APPROVAL LAG SUBMIT BTD---MONTH---MONEY?---MONTH---MONEY?---MONTH--MONEY?---MONTH... December 15, 2023
V.TLT	RE:QUILT-3.032 Trial - BCG & N-803 for BCG-Unresponsive NMIBC What a nightmare. November 22, 2023
V.TLT	RE:RE:RE:RE:RE:RE:share activity What is clear to me is that if they don't get a partner soon they will... August 18, 2023
V.TLT	Hardware Requirement impact on FDA approval Does requiring a piece of hardware (laser) for the treatment impact the... May 18, 2023
V.TLT	3 (or more) treatments Would a third treatment add significant testing burden (and cost) to... May 13, 2023
V.TLT	RE:RE:RE:RE:RE:RE:RE:RE:I don't see a mystery I've stopped worrying about competitors overall. Usually I don't try... April 18, 2023

Become a member today, It's free!

Bullboard Post History

by Gman620

RE:RE:RE:Impalaman

FDA focused?

RE:RE:Potential US election impact on the FDA?

RE:New Paper by Dr. McFarland

No Money = No leverage

Exciting News.... coming

37 more trial subjects

RE:RE:RE:RE:Quote from Keytruda.com

RE:RE:Quote from Keytruda.com

RE:RE:RE:RE:RE:RE:CG Oncology phase 3 results impossible for TLT to beat?

RE:RE:Incremental cost per study subject?

Incremental cost per study subject?

RE:RE:RE:RE:RE:RE:Dr. Ashish Kamat Interview - BOND-003 Study Results

Green Swimlanes

APPROVAL LAG

RE:QUILT-3.032 Trial - BCG & N-803 for BCG-Unresponsive NMIBC

RE:RE:RE:RE:RE:RE:share activity

Hardware Requirement impact on FDA approval

3 (or more) treatments

RE:RE:RE:RE:RE:RE:RE:RE:I don't see a mystery

Featured News Links

Do you want to stay ahead of the markets? See how DealRoom can help.

Featured Company

Visionstate Corp. V.VIS

Become a member today, It's free!

Sign In

Send my password

Become a member today, It's free!

Bullboard Post History

by Gman620

Featured News Links

Featured Company